Trial intelligence / Profile preview

Multicenter randomized double-blind trial of losartan versus placebo on aortic dilation in Marfan syndrome

2006-006112-30Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Marfan syndrome (MFS) and aortic root dilation comparing Losartan (Cozaar) + beta-blocker with Placebo + beta-blocker (2 arms). Started May 2008; status: active.

02

Drugs

losartan
03

Conditions

Marfan syndrome (MFS)aortic root dilation

Beyond the preview

Go deeper on 2006-006112-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006112-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call